AEQUILIBRIUM PHARMA is a privately held biotech startup founded in 2018 in Milan, Italy, focused on drug discovery using monoclonal antibodies and exosomes for intractable diseases such as pain and aggressive metastatic cancer. It is a drug discovery company, not a contract manufacturer.
Monoclonal antibodies, exosome technology, drug discovery, biosimilar solutions
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.